

House
Study
Bill
519
-
Introduced


HOUSE
FILE
_____


BY
(PROPOSED
COMMITTEE


ON
COMMERCE
BILL
BY


CHAIRPERSON
COWNIE)


A
BILL
FOR


An
Act
relating
to
the
regulation
of
pharmacy
benefit
managers.
1


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
2


TLSB
5250HC
(5)
85


av/nh



H.F.
_____


Section
1.
Section
510B.1,
Code
2014,
is
amended
by
adding
1


the
following
new
subsection:
2


NEW
SUBSECTION


.
5A.
“Maximum
reimbursement
amount”
means
3


the
maximum
reimbursement
amount
for
a
therapeutically
and
4


pharmaceutically
equivalent
multiple-source
prescription
drug
5


that
is
listed
in
the
most
recent
edition
of
the
publication
6


entitled
approved
drug
products
with
therapeutic
equivalence
7


evaluations,
published
by
the
United
States
food
and
drug
8


administration,
otherwise
known
as
the
orange
book.
9


Sec.
2.
NEW
SECTION
.
510B.8
Proof
of
financial
solvency.
10


1.
The
commissioner
may
require
a
pharmacy
benefits
manager
11


to
submit
information
to
the
commissioner
related
to
the
12


pharmacy
benefits
manager’s
financial
solvency
in
accordance
13


with
chapter
507,
including
but
not
limited
to
disclosure
of
14


pricing
methodology
and
rebate
information.
15


2.
For
purposes
of
the
disclosure
of
pricing
methodology,
16


maximum
reimbursement
amounts
shall
be
implemented
as
follows:
17


a.
Established
for
multiple
source
prescription
drugs
18


prescribed
after
the
expiration
of
any
generic
exclusivity
19


period.
20


b.
Established
for
any
prescription
drug
with
at
least
two
21


or
more
A-rated
therapeutically
equivalent,
multiple
source
22


prescription
drugs
with
a
significant
cost
difference.
23


c.
Determined
using
comparable
prescription
drug
prices
24


obtained
from
multiple
nationally
recognized
comprehensive
data
25


sources
including
wholesalers,
prescription
drug
file
vendors,
26


and
pharmaceutical
manufacturers
for
prescription
drugs
that
27


are
nationally
available
and
available
for
purchase
locally
by
28


multiple
pharmacies
in
the
state.
29


3.
For
those
prescription
drugs
to
which
maximum
30


reimbursement
amount
pricing
applies,
a
pharmacy
benefits
31


manager
shall
include
in
a
contract
with
a
pharmacy
information
32


regarding
which
of
the
national
compendia
is
used
to
33


obtain
pricing
data
used
in
the
calculation
of
the
maximum
34


reimbursement
amount
pricing
and
shall
provide
a
process
to
35


-1-


LSB
5250HC
(5)
85


av/nh
1/
4





H.F.
_____


allow
a
pharmacy
to
comment
on,
contest,
or
appeal
the
maximum
1


reimbursement
amount
rates
or
maximum
reimbursement
amount
2


list.
The
right
to
comment
on,
contest,
or
appeal
the
maximum
3


reimbursement
amount
rates
or
maximum
reimbursement
amount
list
4


shall
be
limited
in
duration
and
allow
for
retroactive
payment
5


in
the
event
that
it
is
determined
that
maximum
reimbursement
6


amount
pricing
has
been
applied
incorrectly.
7


4.
For
purposes
of
the
disclosure
of
rebate
information,
8


the
commissioner,
in
conjunction
with
an
examination
authorized
9


under
this
chapter
or
chapter
507,
507B,
or
510,
may
request,
10


and
a
pharmacy
benefits
manager
shall
disclose
to
the
11


commissioner,
the
amount
of
all
rebate
revenues
and
the
nature,
12


type,
and
amounts
of
all
other
revenues
that
the
pharmacy
13


benefits
manager
receives
from
each
pharmaceutical
manufacturer
14


or
labeler
with
whom
the
pharmacy
benefits
manager
has
a
15


contract.
The
pharmacy
benefits
manager
shall
disclose
to
the
16


commissioner,
including
but
not
limited
to
all
of
the
following
17


information:
18


a.
Both
the
aggregate
amount,
and
the
specific
amounts
for
19


each
prescription
drug,
of
all
rebates
and
other
retrospective
20


utilization
discounts
received
by
the
pharmacy
benefits
21


manager,
directly
or
indirectly,
from
each
pharmaceutical
22


manufacturer
or
labeler
that
are
earned
in
connection
with
the
23


dispensing
of
prescription
drugs
to
covered
individuals
of
24


the
health
benefit
plans
issued
by
a
pharmacy
or
for
which
a
25


pharmacy
is
the
designated
administrator.
26


b.
The
nature,
type,
and
amount
of
all
other
revenue
27


received
by
the
pharmacy
benefits
manager
directly
or
28


indirectly
from
each
pharmaceutical
manufacturer
or
labeler
for
29


any
other
products
or
services
provided
to
the
pharmaceutical
30


manufacturer
or
labeler
by
the
pharmacy
benefits
manager
with
31


respect
to
programs
that
a
pharmacy
offers
or
provides
to
32


covered
individuals.
33


c.
Any
prescription
drug
utilization
information
requested
34


by
a
pharmacy
relating
to
covered
individuals.
35


-2-


LSB
5250HC
(5)
85


av/nh
2/
4



H.F.
_____


EXPLANATION
1


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
2


the
explanation’s
substance
by
the
members
of
the
general
assembly.
3


This
bill
relates
to
the
regulation
of
pharmacy
benefit
4


managers.
The
bill
authorizes
the
commissioner
of
insurance
5


to
require
a
pharmacy
benefits
manager
to
submit
information
6


to
the
commissioner
related
to
the
pharmacy
benefit
manager’s
7


financial
solvency,
including
information
disclosing
8


pricing
methodology
and
rebates
received,
pursuant
to
the
9


commissioner’s
power
to
examine
insurance
companies
under
Code
10


chapter
507.
11


The
bill
provides
that
for
purposes
of
the
disclosure
of
12


pricing
methodology,
a
pharmacy
benefits
manager
must
use
13


maximum
reimbursement
amounts
that
meet
specified
criteria.
14


“Maximum
reimbursement
amount”
is
defined
as
the
maximum
15


reimbursement
amount
for
a
therapeutically
and
pharmaceutically
16


equivalent
multiple-source
prescription
drug
that
is
listed
in
17


the
United
States
food
and
drug
administration’s
publication
18


entitled
approved
drug
products
with
therapeutic
equivalence
19


evaluations,
otherwise
known
as
the
orange
book.
20


For
those
prescription
drugs
to
which
maximum
reimbursement
21


amount
pricing
applies,
a
pharmacy
benefits
manager
must
22


include
information
in
a
contract
with
a
pharmacy
showing
how
23


maximum
reimbursement
amount
pricing
is
calculated
and
allowing
24


the
pharmacy
the
opportunity
to
comment
on,
contest,
or
appeal
25


the
maximum
reimbursement
amount
rates
and
list.
The
contract
26


must
also
allow
for
retroactive
payment
if
it
is
determined
27


that
maximum
reimbursement
amount
pricing
has
been
applied
28


incorrectly.
29


The
bill
also
provides
that
for
purposes
of
disclosure
of
30


rebate
information,
the
commissioner
in
conjunction
with
an
31


examination
authorized
under
Code
chapter
507
(examination
32


of
insurance
companies),
507B
(regulation
of
insurance
trade
33


practices),
510
(regulation
of
managing
general
agents
and
34


third-party
administrators),
or
510B
(regulation
of
pharmacy
35


-3-


LSB
5250HC
(5)
85


av/nh
3/
4



H.F.
_____


benefits
managers),
can
request
information
from
a
pharmacy
1


benefits
manager
concerning
the
amount
of
all
rebate
revenues,
2


and
the
nature,
type,
and
amounts
of
all
other
revenues
that
3


the
pharmacy
benefits
manager
receives
from
each
pharmaceutical
4


manufacturer
or
labeler
with
whom
the
pharmacy
benefits
5


manager
has
a
contract.
The
bill
specifies
information
which
6


a
pharmacy
benefits
manager
must
disclose
pursuant
to
such
a
7


request
by
the
commissioner.


8


-4-


LSB
5250HC
(5)
85


av/nh
4/
4

